BCAL Diagnostics Ltd
ASX:BDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BCAL Diagnostics Ltd
ASX:BDX
|
AU |
|
I
|
Isracann Biosciences Inc
CNSX:IPOT
|
CA |
|
Fragrant Prosperity Holdings Ltd
LSE:FPP
|
VG |
|
Asset Plus Ltd
NZX:APL
|
NZ |
|
Lautan Luas Tbk PT
IDX:LTLS
|
ID |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
Red Mountain Mining Ltd
ASX:RMX
|
AU |
|
C
|
ConvaTec Group PLC
SWB:2CV
|
UK |
|
M
|
Many Peaks Minerals Ltd
ASX:MPK
|
AU |
Shareholder Yield
Current shareholder yield for BDX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BDX Price
BCAL Diagnostics Ltd
| Average Annual Return | -6.7% |
| Standard Deviation of Annual Returns | 50.34% |
| Max Drawdown | -77% |
| Market Capitalization | 25m AUD |
| Shares Outstanding | 368 680 000 |
| Percentage of Shares Shorted |
N/A
|
